Authors

• Vasily Andrianov (ORCID: https://orcid.org/0009-0005-1895-9126)
• Nabil F. Saba (ORCID: https://orcid.org/0000-0003-4972-1477)
• Lisa Francesca Licitra (ORCID: https://orcid.org/0000-0003-0623-4118)
• Jean‐Pascal Machiels (ORCID: https://orcid.org/0000-0001-6369-9742)
• Kevin Joseph Harrington (ORCID: https://orcid.org/0000-0002-6014-348X)
• Robert I. Haddad (ORCID: https://orcid.org/0000-0003-1413-0079)
• Taylor Jew
• Cixin He

Institutions

• Cliniques Universitaires Saint-Luc (BE)
• Emory University (US)
• Exelixis (United States) (US)
• University of Milan (IT)
• Royal Ottawa Mental Health Centre (CA)
• Cancer Institute (WIA) (IN)
• Institute of Cancer Research (CA)
• Dana-Farber Cancer Institute (US)
• Royal Marsden Hospital (GB)
• Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
• UCLouvain (BE)

Publication Details

Journal

Future Oncology

Published

2025-04-18

DOI

https://doi.org/10.1080/14796694.2025.2485015

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Exelixis